These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects. Nathanson JA. Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744 [Abstract] [Full Text] [Related]
9. Effects of topical carteolol and timolol on tissue circulation in the iris and choroid. Tomidokoro A, Araie M, Tamaki Y, Muta K. Curr Eye Res; 1999 May; 18(5):381-90. PubMed ID: 10373001 [Abstract] [Full Text] [Related]
10. Additive intraocular pressure reducing effect of topical timolol during systemic beta-blockade. Marén N, Alvan G, Calissendorff BM, Haglund K, Seideman P. Acta Ophthalmol (Copenh); 1982 Feb; 60(1):16-23. PubMed ID: 6127860 [Abstract] [Full Text] [Related]
13. [The influence of RS-Timolol in comparison with R-Timolol and S-Timolol on the intraocular pressure in water-loaded rabbits]. Czechowicz-Janicka K, Kamińska E, Staszkiewicz J, Terelak-Borys B, Oledzka K, Danysz A. Klin Oczna; 1998 Feb; 100(5):259-61. PubMed ID: 9884519 [Abstract] [Full Text] [Related]
14. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs. Svec AL, Strosberg AM. Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005 [Abstract] [Full Text] [Related]